Introduction: Chronic spontaneous urticaria (CSU) is a frequent disorder in which activation
of effector cells and histamine release can be induced via several distinct pathogenetic …

Chronic spontaneous urticaria (CSU) is defined by the appearance of wheals and a variable
presence of angioedema which persists for at least 6 weeks. It represents the most common …

Background: Chronic spontaneous urticaria (CSU) is defined as the recurrence of
unprovoked transient wheals and itch for more than 6 weeks. Currently, there is an unmet …

Summary Background. Baseline total IgE levels have recently emerged as a prognostic
factor for the clinical response to omalizumab in patients with severe chronic spontaneous …

Background. Currently there are no biomarkers useful to predict the future evolution and the
therapeutic response in patients with chronic spontaneous urticaria (CSU). Objective. To …

Chronic spontaneous urticaria (CSU) is defined as the appearance of evanescent wheals,
angioedema, or both, for at least 6 weeks. CSU is associated with intense pruritus and poor …

Chronic spontaneous urticaria (CSU), a distressing skin condition characterized by the
recurrent appearance of hives (wheals), angioedema, or both, affects up to 2% of the …

Chronic spontaneous urticaria (CSU) is a mast cell‐driven disease that is defined as the
recurrence of weals, angioedema or both for> 6 weeks due to known or unknown causes. As …

Chronic urticaria (CU) is a mast cell-driven disease characterized by the development of
wheals, angioedema, or both for more than 6 weeks. The two major sub-types are chronic …

Omalizumab is a monoclonal anti‐IgE antibody which is effective in chronic spontaneous
urticaria (CSU), although clinical response appears to be variable in the real‐life setting. The …